Table 1. The optimization of the pig fibroblasts transfected with ZFNs.
ZFNs | ZFNs type | ZFNs amount | mutations |
---|---|---|---|
set 1 | plasmid | 0.5 μg | 0/30 (0) |
plasmid | 1 μg | 2/97 (2.04%) | |
plasmid | 2 μg | 0/32 (0) | |
mRNA | 2 μg | 0/ 95 (0) | |
plasmid | 4 μg | 0/98 (0) | |
set 2 | plasmid | 0.5 μg | 1/96 (1.04%) |
plasmid | 1 μg | 3/94 (3.19%) | |
plasmid | 2 μg | 2/66 (3.03%) | |
mRNA | 2 μg | 0/91 (0) | |
plasmid | 4 μg | 18/80 (22.5%) |
ZFNs activities were determined by TA cloning and Sanger sequencing.